Comparative study between the usage of corifollitropin alfa and daily recombinant FSH in the ovarian stimulation of low responders

Trial Profile

Comparative study between the usage of corifollitropin alfa and daily recombinant FSH in the ovarian stimulation of low responders

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2016

At a glance

  • Drugs Corifollitropin alfa (Primary) ; Follicle stimulating hormones; Follicle stimulating hormones; Menotropin
  • Indications Female infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jan 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 24 Aug 2015 Planned End Date changed from 1 Dec 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
    • 24 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top